Pentosan Polysulfate-A "Better Heparin" as Potential Medication for the Treatment of SARS-CoV-2 Infections?

Thromb Haemost. 2022 Jun;122(6):870. doi: 10.1055/a-1815-2142. Epub 2022 Apr 1.
No abstract available

MeSH terms

  • COVID-19 Drug Treatment*
  • Heparin / adverse effects
  • Humans
  • Pentosan Sulfuric Polyester* / therapeutic use
  • SARS-CoV-2

Substances

  • Pentosan Sulfuric Polyester
  • Heparin